Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.364EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.364ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.364ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.364EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.364EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.364ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.364ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KD.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KD.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XCSEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XCSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XCSECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XCSECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XCSEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XCSEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XCSENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XCSENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
GA.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
GA.7.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
GA.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
GA.7.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
GA.7.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
GA.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.15.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.15.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.15.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.15.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.15.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.15.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.15.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.15.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.40EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.40ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.40ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.40EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.40EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CR.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CR.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CR.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CR.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CR.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CR.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CR.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.6EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.6EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used